EMEA-000288-PIP01-08-M02

Invented name	Avalox and associated names; Octegra and associated names; Actimax and associated names; Actira and associated names
Active substance	Moxifloxacin hydrochloride
Therapeutic area	Infectious diseases
Decision number	P/230/2010
PIP number	EMEA-000288-PIP01-08-M02
Pharmaceutical form(s)	Film-coated tablet Solution for infusion Granules and solvent for oral suspension
Condition(s) / indication(s)	Acute Exacerbation of Chronic Bronchitis Community Acquired Pneumonia Complicated Intra-Abdominal Infection Complicated Skin and Skin Structure Infections Pelvic Inflammatory Disease Treatment of acute bacterial sinusitis
Route(s) of administration	Oral use Intravenous use
Contact for public enquiries	Bayer Schering Pharma AG pediatrics.medical-affairs-europe@bayerhealthcare.com Germany Phone: +49 3046815333 Fax: +49 3046895333
Decision type	PM: decision on the application for modification of an agreed PIP

Add your rating

★ ★ ★ ★ ★